[PDF] Top 20 Nasopharyngeal and serological anti SARS-CoV-2 IgG/IgA responses in COVID-19 patients
Has 10000 "Nasopharyngeal and serological anti SARS-CoV-2 IgG/IgA responses in COVID-19 patients" found on our website. Below are the top 20 most common "Nasopharyngeal and serological anti SARS-CoV-2 IgG/IgA responses in COVID-19 patients".
Nasopharyngeal and serological anti SARS-CoV-2 IgG/IgA responses in COVID-19 patients
... In this study, we used an in-house ELISA [13] to detect IgG and IgA directed against the SARS- CoV-2 Nucleoprotein (N) in the NPS and in the ... Voir le document complet
18
Challenges and Issues of Anti-SARS-CoV-2 Vaccines
... observed in most viral infections: rapid production of IgM-antibodies (peak at 10 days) then rising of IgG with a peak around 20 days to decline onwards ( 8 , 9 ...of patients will have produced ... Voir le document complet
12
Distinct systemic and mucosal immune responses to SARS-CoV-2
... local and systemic immune responses are dysregulated following SARS-CoV-2 infection and the individual roles that they play in determining severe clinical outcomes ... Voir le document complet
41
IgA dominates the early neutralizing antibody response to SARS-CoV-2
... Mucosal IgA is a SARS-CoV-2 neutralizing agent These observations detail the contributions of IgA and IgG to systemic humoral ...main SARS-CoV-2 ... Voir le document complet
15
Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?
... * and Loïc Guillot 2 1 INSERM UMR1152, Laboratoire d’Excellence Inflamex, Faculté de Médecine, Hôpital Bichat, Université de Paris, Paris, France, 2 Sorbonne Université, INSERM UMR S 938, Centre de ... Voir le document complet
10
Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance
... Charneau 2 , Daniel Lévy-Bruhl 1 , Sylvie van der Werf 5,15,17 & Harold Noel 1,17 Assessment of the cumulative incidence of SARS-CoV-2 infections is critical for monitoring the course ... Voir le document complet
8
Immune responses during COVID-19 infection
... during COVID-19 occurs at the same timing as the one described post- SARS-CoV ...from patients with a high suspicion of COVID-19 infec- tion using an enzyme-linked ... Voir le document complet
25
Serological signatures of SARS-CoV-2 infection: Implications for antibody-based diagnostics
... coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19) emerged in Wuhan, China in December ...recorded in nearly every country in the ... Voir le document complet
41
Kinetics of Anti–SARS-CoV-2 IgG Antibodies in Hemodialysis Patients Six Months after Infection
... navirus 2 (SARS-CoV-2) is poorly un- ...to SARS-CoV-2 (specifically, IgG against nucleocapsid and spike antigens), in 83 patients on ... Voir le document complet
15
Retrouver les origines du SARS-CoV-2 dans les phylogénies de coronavirus
... du SARS- Cov-2, plus spécifiquement dans la région codant pour le domaine de liaison au récepteur cellulaire ...le SARS-Cov-2 tombe à 70 %, alors qu’il est supérieur à 96 % ... Voir le document complet
14
Syndrome de Guillain-Barré et infection au SARS-CoV-2
... 3. Guijarro-Castro C, Roson-Gonzales M, Abreu A, et al. Guillain-Barré syndrome associated with SARS-CoV-2 infection. Comments after 16 published cases. Neurologia 2020 ; 35 : 412-5. 4. De Sanctis ... Voir le document complet
2
Immunité adaptative contre le virus SARS-CoV-2
... le SARS-CoV-2 (sans nécessité d’une ...les patients cliniquement diagnos- tiqués mais dont l’infection n’a pas été confirmée par un test moléculaire par RT-PCR, (reverse transcription-poly- ... Voir le document complet
6
Chemoinformatic Analysis of Psychotropic and Antihistaminic Drugs in the Light of Experimental Anti-SARS-CoV-2 Activities
... have SARS-CoV-2 cytopathic effect. Figure 2 Bioactive compounds (161 molecules) clustered according to the presence of organic functional ...toxic in human fibroblast toxicity assay) or ... Voir le document complet
16
Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients
... L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignemen[r] ... Voir le document complet
8
Comorbid illnesses are associated with altered adaptive immune responses to SARS-CoV-2
... limitations in study design and to more comprehensively examine the functional profiles of antigen-specific immune responses and their association with risk factors and clinical ... Voir le document complet
20
Intérêt du suivi des patients suspects ou atteints du SARS-COV-2 par une application smartphone interactive
... Concernant le questionnaire de retour d’expérience des utilisateurs, le taux de réponse n’est que de 17,9%. Il existe ici un biais de sélection (de volontariat) car la représentativité de cet échantillon n’est pas ... Voir le document complet
49
Increased risks of SARS-CoV-2 Nosocomial Acquisition in high-risk COVID-19 units justify personal Protective Equipment: a cross sectional study
... In- creased risks of SARS-CoV-2 Nosocomial Acquisition in high-risk COVID-19 units justify personal Protective Equipment: a cross sectional study.[r] ... Voir le document complet
7
Interrupting vaccination policies can greatly spread SARS-CoV-2 and enhance mortality from COVID-19 disease: the AstraZeneca case for France and Italy
... 0.25 [see Ref. 25] 0.2 [see Ref. 20] 0.2 [see Ref. 25] 0.1 [see Ref. 27] 0.0 TABLE I. Model parameters used for our simulations with corresponding references. Initialising parameters with their associated reference are ... Voir le document complet
23
Transplacental transmission of SARS-CoV-2 infection
... gross and microscopic examination were performed according to the Amsterdam Consensus statement 24 ...fixed in 4% buffered formalin and samples were paraffin ...schiff and Gomori-Grocott ... Voir le document complet
8
Retrouver les origines du SARS-CoV-2 dans les phylogénies de coronavirus
... du SARS-CoV-2, isolés à partir de pangolins de Malaisie, a constitué une avancée impor- ...du SARS-CoV-2 (89 % pour la souche MP789, à comparer aux 96 % pour RaTG13) (Figure ... Voir le document complet
15
Sujets connexes